Enjoy complimentary customisation on priority with our Enterprise License!
The global anesthesia drugs market is anticipated to grow at a steady rate and will post a CAGR of more than 3% during the forecast period. The growing volume of surgical procedures will drive the growth prospects for the global anesthesia drugs market in the coming years. Anesthesia is administered during various surgical procedures conducted to treat various diseases such as cardiovascular diseases, gastrointestinal diseases, urological disorders, spinal abnormalities, brain tumors, and orthopedic deformities. The rise in the number of surgical procedures in the European countries will aid in the growth of the market in these locations. For instance, the number of laparoscopic colectomy procedures doubled in Slovenia and tripled in Spain between 2008 and 2014. Some of the surgeries performed in various ambulatory surgical centers (ASCs) include lens and cataract, hernia procedure, cervix and uterus removal, hysterectomy, and transurethral excision.
In terms of geography, the Americas accounted for the maximum market share during 2016 and will continue to dominate the market until the end of 2021. One of the major factors responsible for the market's growth in the US is the growing demand for propofol. Additionally, the increasing focus of a large number of vendors towards exploring new routes of administration such as oral and topical will also drive the preference for anesthetic drugs in the market. Analysts predict that the increasing demand for anesthesia in labor will also drive market growth. According to the Centers for Disease Control and Prevention (CDC), the total number of deliveries including vaginal and caesarean stood at 3,984,502 in the US.
The global anesthesia drugs market is highly fragmented and competitive due to the presence of a large number of regional and international vendors across the globe. Also, it has been estimated that the competitive environment in the market will intensify due to the continuous advancements in technologies and drugs for new routes of administration (ROAs).
Key vendors in this market are -
Other prominent vendors in the market include Air Liquide, Arbor Pharmaceuticals, Avera Pharmaceuticals, Eisai, GSK, Jiangsu HengRui Medicine, Johnson & Johnson, Lannett Company, Merck, Mydent International, Novalar Pharma, Nuvo Pharmaceuticals, Paion UK, Pfizer, Primex Pharmaceuticals, St. Renatus, Takeda, and The Medicines Company.
The parenteral anesthesia segment accounted for the maximum market share during 2016 and will continue to dominate the market during the next few years as well. One of the major factors responsible for its increasing adoption among end-users is the fewer side effects in comparison to the inhalation therapy. Also, intravenous anesthesia is a segment of parenteral drugs, which is highly preferred by physicians because of its increased effectiveness.
The general anesthesia drugs segment accounted for the maximum market share during 2016 and will continue to dominate the market for the next four years. It has been estimated that the market will further benefit from the rising incidences of chronic respiratory diseases, cardiovascular diseases, craniomaxillofacial surgeries, and accidents along with the rapid adoption of propofol.
Technavio also offers customization on reports based on specific client requirement.
By identifying short- and long-term trends in customer behavior, growth potential, competitors, and challenges, research analysts at Technavio provide a comprehensive collection of industry research reports on the various aspects of the orthopedics and general medical devices sector. With an up-to-date analysis, the market research experts from Technavio also provide detailed information on several vendors, including Drägerwerk, GE Healthcare, Maquet, Mindray Medical International, Penlon, Philips Healthcare, Meditec, Oricare, and Spacelabs Healthcare, who have established a strong presence in both the global and regional markets.
To identify the industry's growth prospects, the market research analysts at Technavio follow a triangulated mix of primary and secondary research techniques and consider factors like market size and the demand for various products across different geographical regions. Furthermore, by analyzing various parameters such as the changing preferences of customers and the products and services offered by competitors, our upcoming market research report on anesthesia drugs for the forecast period of 2017 to 2021 helps clients understand the constantly changing landscape for the orthopedics and general medical devices sector, which is an integral part of the global healthcare and life sciences industry.
This upcoming report on anesthesia drugs also considers the growth of similar markets such as anesthesia resuscitators and anesthesia delivery systems, which are expected to grow at a CAGR of more than 3% and more than 6%, respectively by 2020. Analysts identify that the increasing incidences of chronic disorders will foster the need for surgical procedures as one of the major factors that will fuel market growth. Increasing collaborations among hospitals and healthcare departments with anesthesia drug manufacturers will also increase the revenue shares of market players. In addition to syndicated reports, Technavio also offers to provide high-quality customized reports based on the requirements of the customers and helps businesses identify new growth opportunities and develop effective strategies to optimize their market positions.
The upcoming industry research report for anesthesia drugs also identifies the key drivers, emerging trends, as well as the challenges currently experienced by the healthcare and life sciences industry. It also presents insights into the changing competitive landscape to give clients a realistic picture of the future direction of the orthopedics and general medical devices sector.
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Research Methodology
PART 04: Introduction
PART 05: An overview of anesthesia
PART 06: Key clinical trials
PART 07: Market landscape
PART 08: Market segmentation by ROA
PART 09: Market segmentation by type
PART 10: Geographical segmentation
PART 11: Market drivers
PART 12: Impact of drivers
PART 13: Market challenges
PART 14: Impact of drivers and challenges
PART 15: Market trends
PART 16: Vendor landscape
PART 17: Key vendor analysis
PART 18: Appendix
PART 19: Explore Technavio
Tags: drug interactions, general anesthesia, radiation treatment, in vitro diagnostics, in-vitro diagnostics market segmentation, healthcare market analysis,
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.